SIM
CLCD

Strategic Investment Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Strategic Investment Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,876
Closed -$323K – 114
2016
Q4 		$323K Buy
+8,876
New +$314K 0.03% 36

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Strategic Investment Management's CLCD Position: Q1 2017 in Review

Strategic Investment Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 8,876 shares — an estimated $323K sold.

Strategic Investment Management first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $323K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Strategic Investment Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Strategic Investment Management sold 8,876 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $323K.
  • Strategic Investment Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Strategic Investment Management's CoLucid Pharmaceuticals, Inc. position peaked at $323K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Strategic Investment Management's 13F filing for Q1 2017, filed 15 May 2017.